![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: NEDD8 |
Gene summary for NEDD8 |
![]() |
Gene information | Species | Human | Gene symbol | NEDD8 | Gene ID | 4738 |
Gene name | NEDD8 ubiquitin like modifier | |
Gene Alias | NEDD-8 | |
Cytomap | 14q12 | |
Gene Type | protein-coding | GO ID | GO:0006139 | UniProtAcc | Q15843 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
4738 | NEDD8 | CA_HPV_1 | Human | Cervix | CC | 7.40e-08 | -1.65e-01 | 0.0264 |
4738 | NEDD8 | N_HPV_2 | Human | Cervix | N_HPV | 1.17e-02 | 6.72e-02 | -0.0131 |
4738 | NEDD8 | CCI_1 | Human | Cervix | CC | 7.92e-18 | -8.86e-01 | 0.528 |
4738 | NEDD8 | CCI_2 | Human | Cervix | CC | 1.63e-16 | -8.86e-01 | 0.5249 |
4738 | NEDD8 | CCI_3 | Human | Cervix | CC | 4.32e-23 | -8.86e-01 | 0.516 |
4738 | NEDD8 | CCII_1 | Human | Cervix | CC | 4.60e-31 | -8.86e-01 | 0.3249 |
4738 | NEDD8 | sample3 | Human | Cervix | CC | 1.07e-02 | 6.26e-02 | 0.1387 |
4738 | NEDD8 | L1 | Human | Cervix | CC | 4.04e-07 | -2.94e-01 | 0.0802 |
4738 | NEDD8 | HTA11_3410_2000001011 | Human | Colorectum | AD | 9.94e-30 | 4.89e-01 | 0.0155 |
4738 | NEDD8 | HTA11_2487_2000001011 | Human | Colorectum | SER | 2.65e-28 | 6.92e-01 | -0.1808 |
4738 | NEDD8 | HTA11_2951_2000001011 | Human | Colorectum | AD | 1.84e-10 | 4.66e-01 | 0.0216 |
4738 | NEDD8 | HTA11_1938_2000001011 | Human | Colorectum | AD | 1.12e-36 | 8.32e-01 | -0.0811 |
4738 | NEDD8 | HTA11_78_2000001011 | Human | Colorectum | AD | 7.41e-14 | 3.52e-01 | -0.1088 |
4738 | NEDD8 | HTA11_347_2000001011 | Human | Colorectum | AD | 4.93e-42 | 6.87e-01 | -0.1954 |
4738 | NEDD8 | HTA11_411_2000001011 | Human | Colorectum | SER | 9.29e-21 | 1.13e+00 | -0.2602 |
4738 | NEDD8 | HTA11_2112_2000001011 | Human | Colorectum | SER | 7.77e-16 | 8.81e-01 | -0.2196 |
4738 | NEDD8 | HTA11_3361_2000001011 | Human | Colorectum | AD | 1.34e-28 | 6.96e-01 | -0.1207 |
4738 | NEDD8 | HTA11_83_2000001011 | Human | Colorectum | SER | 6.65e-20 | 5.95e-01 | -0.1526 |
4738 | NEDD8 | HTA11_696_2000001011 | Human | Colorectum | AD | 6.81e-50 | 8.27e-01 | -0.1464 |
4738 | NEDD8 | HTA11_866_2000001011 | Human | Colorectum | AD | 1.29e-28 | 5.08e-01 | -0.1001 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00451162 | Cervix | CC | protein neddylation | 7/2311 | 18/18723 | 3.99e-03 | 2.48e-02 | 7 |
GO:00451163 | Endometrium | AEH | protein neddylation | 7/2100 | 18/18723 | 2.29e-03 | 1.74e-02 | 7 |
GO:004511611 | Endometrium | EEC | protein neddylation | 7/2168 | 18/18723 | 2.76e-03 | 1.97e-02 | 7 |
GO:00451166 | Esophagus | HGIN | protein neddylation | 8/2587 | 18/18723 | 1.58e-03 | 1.79e-02 | 8 |
GO:004511614 | Esophagus | ESCC | protein neddylation | 15/8552 | 18/18723 | 1.20e-03 | 5.88e-03 | 15 |
GO:0045116 | Liver | Cirrhotic | protein neddylation | 11/4634 | 18/18723 | 1.13e-03 | 7.73e-03 | 11 |
GO:00451161 | Liver | HCC | protein neddylation | 15/7958 | 18/18723 | 4.74e-04 | 3.12e-03 | 15 |
GO:00451165 | Oral cavity | OSCC | protein neddylation | 13/7305 | 18/18723 | 4.45e-03 | 1.79e-02 | 13 |
GO:004511613 | Oral cavity | LP | protein neddylation | 11/4623 | 18/18723 | 1.11e-03 | 9.13e-03 | 11 |
GO:004511621 | Oral cavity | NEOLP | protein neddylation | 7/2005 | 18/18723 | 1.75e-03 | 1.21e-02 | 7 |
GO:00451164 | Prostate | BPH | protein neddylation | 10/3107 | 18/18723 | 1.87e-04 | 1.55e-03 | 10 |
GO:004511612 | Prostate | Tumor | protein neddylation | 10/3246 | 18/18723 | 2.72e-04 | 2.24e-03 | 10 |
GO:004511615 | Skin | cSCC | protein neddylation | 14/4864 | 18/18723 | 6.37e-06 | 8.92e-05 | 14 |
GO:004511616 | Thyroid | PTC | protein neddylation | 13/5968 | 18/18723 | 5.21e-04 | 3.37e-03 | 13 |
GO:004511622 | Thyroid | ATC | protein neddylation | 13/6293 | 18/18723 | 9.27e-04 | 4.98e-03 | 13 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
NEDD8 | SNV | Missense_Mutation | c.78N>G | p.Ile26Met | p.I26M | Q15843 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-A2-A0YK-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | cytoxan | SD | |
NEDD8 | SNV | Missense_Mutation | c.74N>A | p.Arg25Gln | p.R25Q | Q15843 | protein_coding | tolerated(0.22) | benign(0.328) | TCGA-AG-3892-01 | Colorectum | rectum adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
NEDD8 | SNV | Missense_Mutation | novel | c.13N>A | p.Val5Met | p.V5M | Q15843 | protein_coding | deleterious(0) | possibly_damaging(0.668) | TCGA-AP-A1DV-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
NEDD8 | SNV | Missense_Mutation | novel | c.66N>T | p.Lys22Asn | p.K22N | Q15843 | protein_coding | deleterious(0.03) | probably_damaging(0.957) | TCGA-B5-A1MR-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
NEDD8 | SNV | Missense_Mutation | novel | c.28N>A | p.Gly10Arg | p.G10R | Q15843 | protein_coding | tolerated(0.08) | possibly_damaging(0.725) | TCGA-B5-A3FA-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
NEDD8 | SNV | Missense_Mutation | c.74N>A | p.Arg25Gln | p.R25Q | Q15843 | protein_coding | tolerated(0.22) | benign(0.328) | TCGA-05-4403-01 | Lung | lung adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
NEDD8 | SNV | Missense_Mutation | novel | c.67N>A | p.Val23Met | p.V23M | Q15843 | protein_coding | deleterious(0.02) | probably_damaging(0.954) | TCGA-05-4433-01 | Lung | lung adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
NEDD8 | SNV | Missense_Mutation | novel | c.164N>G | p.Thr55Arg | p.T55R | Q15843 | protein_coding | deleterious(0.01) | benign(0.037) | TCGA-DQ-5625-01 | Oral cavity | head & neck squamous cell carcinoma | Female | <65 | I/II | Unknown | Unknown | PD |
NEDD8 | SNV | Missense_Mutation | novel | c.20N>T | p.Thr7Met | p.T7M | Q15843 | protein_coding | deleterious(0.01) | probably_damaging(1) | TCGA-UF-A719-01 | Oral cavity | head & neck squamous cell carcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
Page: 1 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
4738 | NEDD8 | ENZYME | MLN4924 |
Page: 1 |